DIAGNOSING MALNUTRITION IN DIALYSIS PATIENTS USING THE GLOBAL LEADERSHIP INITIATIVE ON MALNUTRITION (GLIM) CRITERIA

 

Certificate Output Instructions

For best output, select "Paper Size" as "A4" and "Margin" as "0" or "None".

To save or print to PDF, please select Print Destination > Save as PDF, enable Background Graphics under "More Settings", then click "Save".

 


 

Certificate Background

   

Presented the abstract " "
(Abstract co-author(s):  )

 

 

E-Poster Presentation

During the congress, E-Posters will be accessible to all participants on the congress website 24/7, as well as in the E-poster stations in the congress center. 

Preparing your E-Poster

Please review the E-Poster format requirements carefully when preparing your E-Poster. Should your E-Poster not meet the mentioned requirements, it may not be displayed as described above.

​E-Poster Submission Deadline

Please prepare and upload your E-Poster no later than March 14, 2026 11.59PM CET. After this date, you will no longer be able to prepare and upload your E-poster and it will not be displayed and accessible on the congress website.​

E-Poster Format Requirements
  • PDF file
  • Layout: Portrait (vertical orientation)
  • One page only (Dim A4: 210 x 297mm or PPT)
  • E-Poster can be prepared in PowerPoint (one (1) PowerPoint slide) but must be saved and submitted as PDF file.
  • File Size: Maximum file size is 2 Megabytes (2 MB)
  • No hyperlinks, animated images, animations, and slide transitions
  • Language: English
  • Include your abstract number
  • E-posters can include QR codes, tables and photos
https://storage.unitedwebnetwork.com/files/1099/bd7e694bb4b529fe9db3aefcf4c1b5a3.pdf
DIAGNOSING MALNUTRITION IN DIALYSIS PATIENTS USING THE GLOBAL LEADERSHIP INITIATIVE ON MALNUTRITION (GLIM) CRITERIA

Please follow the instructions below to input your abstract title.

Abstract titles should be brief and reflect the content of the abstract.

  • The title will not be accepted if it exceeds 25 words.
  • Type in CAPITAL LETTERS.
  • Lowercase may be used for abbreviations only, for example, mRNA.
Bengt
Lindholm
Karin Windahl karin.windahl@ki.se Karolinska Institutet Division of Renal Medicine, Baxter Novum, Department of Clinical Science, Intervention and Technology Stockholm Sweden -
Sintra Eyre sintra.eyre@vgregion.se Sahlgrenska University Hospital Department of Clinical Nutrition Gothenburg Sweden -
Valeria Cecchini valeria.cecchini@ki.se Karolinska Institutet Division of Renal Medicine, Baxter Novum, Department of Clinical Science, Intervention and Technology Stockhom Sweden -
Linda Ersten linda.schiller@vgregion.se Danderyd Hospital Division of Clinical Nutrition and Dietetics, Department of Orthopedics Stockholm Sweden -
Camilla Köhler Chen camilla.kohler-chen@regionstockholm.se Danderyd Hospital Division of Clinical Nutrition and Dietetics, Department of Orthopedics Stockholm Sweden -
Lovisa Sehlin Lännevall lovisa.selin-lannevall@regionstockholm.se Danderyd Hospital Division of Clinical Nutrition and Dietetics, Department of Orthopedics Stockholm Sweden -
Malin Nitschke malin.nitschke@regionstockholm.se Danderyd Hospital Division of Clinical Nutrition and Dietetics, Department of Orthopedics Stockholm Sweden -
Caroline Vallin caroline.e.wallin@regionstockholm.se Karolinska University Hospital Department of Clinical Nutrition Stockholm Sweden -
Yiming Lu yiming.lu@regionstockholm.se Karolinska University Hospital Department of Clinical Nutrition Stockholm Sweden -
Camilla Swanpalmer camilla.swanpalmer@vgregion.se Södra Älvsborgs Hospital Department of Nephrology Borås Sweden -
Linda Schiller linda.schiller@vgregion.se Södra Älvsborgs Hospital Department of Nephrology Borås Sweden -
Alice Sabatino alice.sabatino@ki.se Karolinska Institutet Division of Renal Medicine, Baxter Novum, Department of Clinical Science, Intervention and Technology Stockholm Sweden -
Bengt Lindholm bengt.lindholm@ki.se Karolinska Institutet Division of Renal Medicine, Baxter Novum, Department of Clinical Science, Intervention and Technology Stockholm Sweden *
Tommy Cederholm tommy.cederholm@uu.se Uppsala University Department of Public Health and Caring Sciences Uppsala Sweden -
Carla Maria Avesani carla.avesani@ki.se Karolinska Institutet Division of Renal Medicine, Baxter Novum, Department of Clinical Science, Intervention and Technology Stockholm Sweden -

The GLIM criteria refer to a framework for diagnosing malnutrition in adults in a standardized way in diverse health care settings but its role in patients with kidney failure is less well defined. GLIM combines phenotypic measures such as unintentional weight loss, low body mass index (BMI), and low muscle mass, and etiologic factors including inflammation, reduced dietary intake, and disease burden. According to GLIM, individuals on dialysis treatment fulfill the etiological criteria, since kidney failure and the dialysis procedure impose a significant disease burden. However, by assuming that all patients on dialysis meet the etiological criteria, the prevalence of malnutrition might be overestimated. This study aimed to evaluate the performance of GLIM to diagnose malnutrition in patients on dialysis, to examine whether dialysis itself can serve as the sole etiologic criterion, to identify the most prevalent phenotypic criteria, and to evaluate the feasibility of using GLIM in clinical practice.

In this cross-sectional study, adult patients receiving hemodialysis (HD) and peritoneal dialysis (PD) were recruited from six Swedish dialysis centers. Nutritional assessments were conducted by trained renal dietitians; patients on HD were assessed post-dialysis to minimize the confounding effects of fluid overload.  Phenotypic criteria were assessed using unintentional weight loss (>5% within six months or >10% beyond six months), low BMI (<20 kg/m² if <70 years, <22 kg/m² if ≥70 years), and low muscle mass assessed by calf circumference (<32 cm in women, <33 cm in men) or by arm muscle circumference in case of pitting edema. Etiologic criteria were evaluated using two models: (1) reduced dietary intake (assessed by trained renal dietitians) or inflammation (occasional C-reactive protein ≥3.0 mg/L), and (2) dialysis as the sole disease-related burden. Malnutrition was present when at least one phenotypic and one etiologic criterion were present. Ten dietitians who participated in the study completed a survey regarding their perceptions of the feasibility of using GLIM in routine clinical practice.

Ninety-three patients were included (HD n=57, PD n=36; median age 74 (IQR 59–78) years; 60% men; and 43% with diabetes). The most prevalent phenotypic criterion was low muscle mass (49%), followed by low BMI (15%) and unintentional weight loss (5%). For etiologic criteria, inflammation (CRP≥3,0 mg/L) was present in 50%, low energy intake in 22% and low protein intake in 49%. The prevalence of malnutrition based on the model including at least one positive phenotypic criterion and one etiological criterion, malnutrition was present in 41% of patients, while, when dialysis itself was used as the sole etiologic criterion, malnutrition increased to 55%. The main results from the survey among the dietitians are displayed in Figure 1.

Reduced muscle mass was the most prevalent phenotypic GLIM criterion among dialysis patients, highlighting the importance of muscle mass assessment. Despite the chronic inflammatory milieu associated with kidney failure and dialysis, half of the patients displayed normal CRP values. Therefore, dialysis alone may not sufficiently represent the etiologic criteria within the GLIM framework. Moreover, GLIM seemed to be feasible in the dialysis setting as assessed by the dietitians.

Kewords